Skip to main content
Fig. 2 | BMC Research Notes

Fig. 2

From: The effect of glatiramer acetate, IFNβ-1a, fingolimod, and dimethyl fumarate on the expression of T-bet, IFN-γ, and MEG3 in PBMC of RRMS patients

Fig. 2

Comparative Gene Expression Profiles in RRMS Patients: Comparative analysis of T-bet, MEG3, and IFN-γ gene expressions reveals increased T-bet levels in both treatment-naïve and Fingolimod-treated RRMS patients compared to healthy controls (Ctrls) (p = 0.01, p = 0.001). Notably, MEG3 expression decreases significantly in Fingolimod-treated RRMS patients compared to the treatment-naïve group (p = 0.04), No significant changes were observed in IFN-γ expression among the groups. All Values Represent Mean ± SEM; *P < 0.05, **P < 0.01, ns: nonsignificant

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us